- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
PUF Ventures
Building a Craft Grower for Canada’s Medical Marijuana Market
Overview
PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) is a diversified, growth-oriented company focused on the international cannabis industry. Since acquiring a minority ownership position in AAA Heidelberg in March 2014, PUF has grown significantly and now has ownership interests and partnerships with several medical cannabis related companies. With a goal of becoming a licensed producer in Canada, PUF is also actively pursuing international opportunities to increase shareholder value and create a diversified international cannabis operation.
Company Highlights
- Majority ownership of AAA Heidelberg, a late stage ACMPR applicant with an 8,800-square-foot grow facility located in London, Ontario (with ability to grow to 35,000 square feet)
- PUF to gain immediate access to Canadian medical cannabis market upon AAA receipt of cultivation license.
- 35 percent stake in Solaris Nutraceuticals (formerly PUF Ventures Australia), a private company developing a 1.2 million-square-foot medical cannabis cultivation facility near the city of Casino, New South Wales, Australia. The facility will have the capacity to produce over 100,000 kilograms per year of high quality medical cannabis. MYM Nutraceuticals (CSE: MYM) also owns 35 percent of Solaris Nutraceuticals.
- Minority ownership of Weed Points Loyalty, which has created the first loyalty program that targets the emerging cannabis market by leveraging expertise and technology to create a platform that will allow producers, patients, and consumers to interact and define the future face of cannabis commerce.
- Partnership with industry leader Canopy Growth Corporation, to sell medical cannabis product through Canopy’s Tweed Mainstreet.
- Acquired 100 percent interest in Natures Hemp Corp, a private company developing proprietary hemp-based food and medicinal products in partnership with a major Canadian university.
- Strong leadership with experience in company building and public markets.
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.